Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.98% | 14.01% | -75.61% | 12.71% | 0.25% |
| Total Depreciation and Amortization | 1.77% | 1.80% | 1.83% | -12.80% | 1.63% |
| Total Amortization of Deferred Charges | -9.71% | 1.60% | 71.23% | -19.49% | -9.93% |
| Total Other Non-Cash Items | -23.15% | 26.00% | 43.20% | 50.18% | -24.18% |
| Change in Net Operating Assets | 19.59% | 0.88% | 574.22% | -125.13% | 14,175.00% |
| Cash from Operations | 120.41% | 45.33% | 8.06% | -121.14% | 54.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,500.00% | -- | -- | -100.00% | 441.84% |
| Cash from Investing | 3,500.00% | -- | -- | 149.55% | 441.84% |
| Total Debt Issued | -32.62% | -36.26% | 54.20% | -13.68% | -16.87% |
| Total Debt Repaid | -83.60% | 25.59% | -40.69% | 46.46% | -123.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -156.13% | -44.74% | 66.86% | 102.37% | -74.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |